john-albert-st
John Albert St. Cyr, M.D, MS, PhD
Chief

Regulatory & Clinical Research Institute 
University of Minnesota
Minneapolis, MN 55455, USA
Phone: (763) 767-5325
E-mail:
Congenital@aol.com

Education

1967 Washburn High School Minneapolis, MN, (National Honor Society)
1973 B.A., (Phsl, Summa Cum Laude University of Minnesota
1975 B.S., (Medicine) University of Minnesota
1977 M.S., (Phsl-major, Biochem-minor) University of Minnesota
1980 M.D University of Minnesota
1988 Ph.D., (Surgery-major, Phsl-minor) University of Minnesota

Biography

John A. St. Cyr, MD, PhD, a retired cardiovascular surgeon, received his B.A., M.S., M.D., and Ph.D. degrees from the University of Minnesota, Minneapolis, MN. He completed his general surgical training at the University of Minnesota and completed his cardiovascular surgical fellowship training at the University of Colorado Health Sciences Center in Denver, CO. Dr. St.Cyr has extensive research credentials, is widely published, has received numerous research grants, has numerous patents in various fields of interest, and has presented at many medical/surgical conferences/meetings. Dr. St. Cyr has consulted for many medical companies, such as a surgical/medical consultant for Medtronic, Inc. (Physiological Research Laboratories, a facility of Medtronic, Inc., Minneapolis, MN), a medical/surgical consultant for NAMSA, Inc (Minneapolis, MN), Chief Medical Officer for RCRI, Inc. (Minneapolis, MN), and ImmuMed, Inc. (Minneapolis, MN). Dr. St. Cyr is a member of numerous scientific research, medical, and surgical societies.

Research Interest

  • Myocardial metabolism
  • Congenital and adult Cardiovascular Surgery
  • Congenital Heart Disease
  • Stem Cell Therapies
  • Blood Viscosity
  • Dialysis
  • RBC storage

Scientific Activities

Honors and Awards
  • Summa Cum Laude (B.A., Physiology), University of Minnesota
  • Minnesota Surgical Society Research-Essay Award
  • Drs. R.L. Varco & J.E. Foker, Cardiovascular Scholarship
  • MERCK Award
  • Medical Student Research Award, Minnesota Medical Foundation, University of Minnesota
  • Phi Kappa Phi Honorary Society
  • Individual National Institute of Health Research Service/Fellowship Award
  • Minnesota Heart Association, Grant-in-Aid Research Award
  • Vikings Children's Fund, Grant-in-Aid Research Award, Co-investigator
  • Physician's Recognition Award, American Medical Association
  • Minnesota Heart Association, Grant-in-Aid Research Award
  • Physician's Recognition Award, American Medical Association
  • Physician's Recognition Award, American Medical Association
  • American College of Cardiology, Bristol Laboratories Affiliate Travel Award           
  • Marquis Who's Who in the following categories: West, Science and Engineering,
  • America, World, Midwest, Medicine and Healthcare
  • Who's Who of American Inventors
  • International Who’s Who of Professionals
  • American Directory of Who’s Who in Executives and Businesses
  • Medtronic Inc., Technical Contributor of the Year Award (Aortic valve implant model), 1999
  • America’s Registry of Outstanding Professionals
  • 2000 Outstanding Scientists of the 21st Century (1st Edition)
  • Strathmore Who’s Who
  • Fellow, American Heart Association, Cardiovascular-Thoracic Surgical Division, FAHA
  • Fellow, International Biographical Association, FIBA
  • 2000 Eminent Scientists of Today, International Biographical Association
  • Medtronic, Inc., Honorary Research Award (PRL), Advancing Medical Technology, 2004
  • Madison Who’s Who, 2007
  • Premier International Who’s Who of Outstanding Executives/Professionals, Honorary Member
  • Owen H. Wangensteen Surgical Society, Member

Memberships:

  • Washburn High School, Mpls., MN, Alumni Society, Lifetime member
  • University of Minnesota Alumni Association
  • American Association for the Advancement of Science, Emeritus
  • American Medical Association
  • Hennepin County Medical Society
  • New York Academy for Sciences, Lifetime member
  • Phi Kappa Phi Honorary Society, Lifetime member
  • University of Minnesota Medical Alumni Society
  • Association for Academic Surgeons, Senior Member
  • American Physiological Society, Emeritus Member
  • American Heart Association, Basic Cardiovascular Sciences Council
  • American Heart Association, Cardiovascular Surgery and Anesthesia Council
  • American Heart Association, Cardiopulmonary, Critical Care, Perioperative and Resuscitation Council
  • Minnesota Academy for Sciences
  • University of Colorado Health Sciences Alumni Association
  • University of Colorado Alumni Association
  • International Society for Heart Research, Emeritus member
  • International Biographical Association, Fellow (FIBA)
  • American Heart Association, Cardiovascular-Thoracic Surgery Committee, Fellow (FAHA)
  • Research Council, International Biographical Association
  • St. Jude’s DMC (Data Management Committee)
  • Honorary member, Premier International Who’s Who of Outstanding Professionals
  • Board of Directors, LCTA, LLC         
  • Scientific Advisory Board, ImmuMed, Inc.
  • Owen H. Wangensteen Surgical Society
  • C. Walton & Richard C. Lillehei Surgical Society
  • Research Gate
  • Biotech Buildings Minnesota
  • Pharmaceutical Intelligence
  • Scientific Advisory Board, Perinatale, LLC
  • Scientific Advisory Board, NeoCardial, LLC
  • Clinical Events Committee, Hemostasis, LLC
  • Cardiovascular Nexus
  • Publons
  • Scientific Advisory Board, AXXA Global
  • Academia

Publications

  1. St.Cyr JA: "Measurable effects of hypoxia on the microvascular permeability in the isolated adult rabbit lung," Master's thesis, University of Minnesota, 1977.
  2. Ward HB, Kriett J, St.Cyr JA, Alyono D, Einzig S, Bianco RW, Anderson RW, Foker JE: Relationship between recovery of myocardial ATP levels and cardiac function following ischemia. J Am Coll Cardiol 3(2):544, 1984.
  3. Ward HB, St.Cyr JA, Alyono D, Bianco RW, Kriett JM, Foker JE: Enhanced recovery of ATP levels following global ischemia. Surg 96(2):248, 1984.
  4. Foker JE, Ward HB, St.Cyr JA, Alyono D, Bianco RW, Kriett JM: Enhanced ATP retrun after global ischemia. Eur Heart J 5(suppl):91, 1984.
  5. St.Cyr JA, Bianco RW, Ascher NL, Foker JE: Consequences of ischemia on organ energy metabolism. Trans Proceed 17(1):1468, 1985.
  6. Schneider J, St.Cyr JA, Thompson T, Johnson D, Burke B, Foker JE: The changing spectrum of cystic pulmonary lesions requiring surgical resection in infants. J Thorac Cardiovasc Surg 89(3):332, 1985.
  7. St.Cyr JA, Braunlin E, Moller J, Ring WS, Molina JE, Foker JE: Management of pulmonary atresia and intact ventricular septum. J Am Coll Cardiol 5(2): 477, 1985.
  8. Fath J, St.Cyr J, Constantinides F, Alden P, Ascher N, Bianco R, Foker J, Cerra F: Alterations in amino acid clearance during ischemia predict hepatocellular ATP changes. Surg 98(3):396, 1985.
  9. Einzig S, St.Cyr JA, Bianco RW, Schneider JR, Lorenz E, Foker JE: Myocardial ATP repletion with ribose infusion. Ped Res 19(4):127A,1985.
  10. Schneider JR, St.Cyr JA, Mahoney JR, Bianco RW, Ring WS, Foker JE: Recovery of ATP and return of function after global ischemia. Circ (Part II), 72(4):III_298, 1985.
  11. St.Cyr JA, Shearen J, Delaney JD: New therapeutic approach for mixed anaplastic carcinoma of the thyroid. Minn Med 68(12):893, 1986.
  12. St.Cyr J, Ward H, Kriett J, Alyono D, Einzig S, Bianco R, Anderson R, Foker J: Long term model for evaluation of myocardial metabolic recovery following global ischemia. In: Brautbar, N.(ed), Myocardial and Skeletal Muscle Bioenergetics, AEMB series. New York, NY, PLenum Publishing 194:401, 1986.
  13. Bianco RW, St.Cyr JA, Rasmussen TM, Clack RM, Schneider JR, Shim HS, Sandstad J, Rysavy RB, Foker JE: Canine model for long term evaluation of prosthetic mitral valves. J Surg Res 41(2):134, 1986.
  14. 14.       St.Cyr JA, Bianco RW, Foker JE, Noren G, Staley N, Wang TC, Einzig S: Myocardial high energy phosphate levels in cardiomyopathic turkeys. J Surg Res 41(3):256, 1986.
  15. Kingsley_Hickman P, Sako EY, Andreone PG, St.Cyr JA, Michurski S, Foker JE, From AHL, Petein M, Ugurbil K: 31P NMR measurement of ATP synthesis in perfused intact rat hearts. J Fed Europ Biochem Soc 198(1):159, 1986.
  16. St.Cyr JA, Ward HB, Kriett JM, Alyono D, Einzig S, Bianco RW, Anderson RW, Foker JE: Long term model for evaluation of myocardial metabolic recovery following global ischemia. Adv Exp Med Biol 194:401,1986.
  17. Einzig S, St.Cyr J, Schneider J, Bianco R, Foker J: Maintained myocardial ATP with long term ribose. Ped Res 20(4),Part II:169A, 1986.
  18. Sako EY, Kingsley_Hickman PB, St.Cyr JA, Andreone PG, Ugurbil K, Foker JE: Dobutamine increases efficiency of ATP utilization in the post_ischemic isolated heart. Surg Forum XXXVII:236, 1986.
  19. Sako EY, Kingsley_Hickman PB, St.Cyr JA, Andreone PG, From AHL, Ugurbil K, Foker JE: Effect of ischemia and dobutamine on myocardial ATP production. Circ, Part II, 74(4):II_272, 1986.
  20. St.Cyr JA, Thompson T, Johnson D, Ferrara TB, Foker JE: The diagnosis and treatment of gastroesophageal reflux in infancy. J Thorac Cardiovasc Surg 92(4):661, 1986.
  21. Foker JE, Braunlin EA, St.Cyr JA, Moller JH, Ring WS, Molina JE: Management of pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg 92(4):706, 1986.
  22. St.Cyr JA, Elick BA, Stock P, Freese D, Sharp H, Payne W, Bloomer J, Najarian J, Ascher N: Use of triple therapy and percutaneous needle biopsy to minimize rejection following liver transplantation. Trans Proceed 19(1):2451, 1987.
  23. St.Cyr JA, Ward HB, Molina JE: Successful correction of a thoracic aortic aneurysm_bronchial fistula. J Card Surg 2:109,1987.
  24. St.Cyr JA, Bianco RW, Judd D, Pierpont ME, Staley N, Noren G, Foker JE, Einzig S: A new method of urine collection in turkeys and chickens. Lab Animal Sci 37:566, 1987.
  25. Tveter KJ, St.Cyr JA, Bianco RW, Einzig S, Foker JE: Ribose enhanced recovery of diastolic function after global myocardial ischemia. Ped Res 23:226A, 1988.
  26. St.Cyr JA: "Ribose enhanced recovery of myocardial ATP levels,"Ph.D. thesis, University of Minnesota, 1988.
  27. St.Cyr JA, Lindberg E, Van Tassel R, Gannon PG: Contained rupture of an ascending aortic aneurysm with cystic medial necrosis, two years after blunt chest trauma. Contemp Surg 33(6):20, 1988.
  28. St.Cyr JA, Jamieson SW: Heart lung transplantation. In: Martini N, Vogt_Moykopf I (eds): International Trends in General Thoracic Surgery. Thoracic Surgery: Frontiers and Uncommon Neoplasms. CV Mosby Co, St.Louis, Baltimore, Toronto, Vol 5:99, 1989.
  29. St.Cyr JA, Schneider JR, Mahoney JR, Bianco RW, Tveter KJ, Einzig S, Foker JE: Enhanced high energy phosphate recovery with ribose infusion after global myocardial ischemia in a canine model. J Surg Res 45:157,1989.
  30. St.Cyr JA, Ferrara TB, Thompson T, Johnson D, Foker JE: Treatment of pulmonary manifestations of gastroesophageal reflux in children two years of age or less. Am J Surg 157:400, 1989.
  31. Tveter K, St.Cyr J, Schneider J, Bianco R, Foker J: Enhanced recovery of diastolic function after global myocardial ischemia in the intact animal. J Am Coll Cardiol 13(2,A):130A, 1989.
  32. Bensard DA, St.Cyr JA, Johnston MR: Acute pleuritic chest pain and lung mass in an elderly female. Chest 97(6):1473, 1990.
  33. St.Cyr JA: Myocardial ischemia is irrelevant. In: Harken A (ed), Surgical Debates III, Philadelphia_Toronto, BC Decker Inc, Vol III:185, 1990.
  34. Read R, St.Cyr JA, Tornabene S, Whitman GJ: Improved cannulation method for extracorporeal membrane oxygenation (ECMO). Ann Thorac Surg 50(4):670, 1990.
  35. Durmowitz A, St.Cyr J, Clarke D, Stenmark K: Unilateral pulmonary hypertension as a result of chronic increased flow to one lung. Amer Rev Resp Dis 142(1):230, 1990.
  36. Read R, St.Cyr J, Manek J, Whitman G, Hopeman A: Bronchial anomaly of the right upper lobe; a case report with a discussion of the literature. Ann Thorac Surg 50(6):980, 1990.
  37. Fullerton DA, Kirson LE, St.Cyr J, Kennard T, Whitman GJR: Human pulmonary vascular resistance (PVR) is hydrogen ion not pCO2 sensitive. J Surg Res 49(4): 375, 1990.
  38. Jones RL, St.Cyr JA, Tornabene SP, Lauber B, Harken AH: Reversible pulmonary hypertension secondary to mitral valvular disease as an indication for extracorporeal membrane oxygenation. Cardiovasc & Vasc Anesth 5(5):494, 1991.
  39. Fullerton DA, St.Cyr J, Campbell DN, Clarke DR, Toews WH, See WM: The Bezold_Jarisch reflex in postoperative pediatric cardiac surgical patients. Ann Thorac Surg 52(3):534, 1991.
  40. St.Cyr JA, Fullerton DA: Letter to the editor Aortic replacement with sutureless intraluminal graft. Texas Heart Instit J 18(2):144-45, 1991.
  41. St.Cyr JA, Fullerton DA, Harken AH: Repair of the torn friable right atrium following decannulation. Ann Thorac Surg 52(6):1344, 1991.
  42. Grosso MA, Banerjee A, St.Cyr JA, Rogers KG, Brown JM, Clarke DR, Harken AH: Cardiac 5'_nucleotidase increases with age and inversely relates to recovery from ischemia. J Thorac Cardiovasc Surg 103(2):206-209, 1992.
  43. St.Cyr JA, Bolman III RM, Foker JE: Cardiac transplantation following the modified Fontan procedure. Editorial, Trans Sci 2(1):3, 1992.
  44. St.Cyr JA, Campbell DN, Fullerton DA, Grosso M, Bishop DA, Clarke DR: Cryoperserved allograft repair of aortic hypoplasia-interrupted aortic arch. Ann Thorac Surg 53(6):1110, 1992.
  45. St.Cyr JA, Fullerton DA: Successful repair of a pseudoaneurysm, originating from a true left ventricular aneurysm. Am Heart Jour 124(5):1381, 1992.
  46. DeMarco C, Alonso K, Nardi C, Pontiggio P, Mathe G, Zablow A, St.Cyr J, Shecterle L: Hyperthermia: An effective AIDS treatment. PWA Coalition Newsline 86:17-21, 1993.
  47. Irwin E, Clack R, Lang G, St.Cyr J, Runge W, Foker J, Bianco R: Long term evaluation of prosthetic mitral valves in sheep. J Invest Surg 6(2):133, 1993.
  48. Fullerton DA, Kirson L, St.Cyr JA, Kinnard T, Whitman GJR: Influence of hydrogen ion concentration versus carbon dioxide tension on pulmonary vascular resistance after cardiac operation. J Thorac Cardiovasc Surg 106(3):528, 1993.
  49. Fullerton DA, Kirson LE, St.Cyr JA, Albert JD, Whitman GJR: The influence of respiratory acid-base status of adult pulmonary vascular resistance before and after cardiopulmonary bypass. Chest 103(4):1091, 1993.
  50. Esper E, Krabill KA, St.Cyr JA, Patton C, Foker JE: Repair of multiple mycotic aortic aneurysms in a young infant with reviewof the literature. J Ped Surg 28(12):1553, 1993.
  51. St.Cyr JA: US Patent, “Suture Removal Device,”USP5250052, 1993.
  52. St.Cyr JA: Who’s Who of American Inventors, 1994-95 edition, page 142, 1994.
  53. St.Cyr JA, Shecterle LM: Low flow extracorporeal hyperthrmia treatment in HIV infected patients with Kaposi's Sarcoma, Phase I clinical protocol, copyrighted 1993, 1996.
  54. Fullerton DA, St.Cyr JA, Albert JA, Grover FL: Hemodynamic advantages of left atrial epinephrine administration after cardiac operations. Ann Thorac Surg 56(6):1263, 1993.
  55. Shecterle LM, St.Cyr JA: Does hyperthermia have a therapeutic role in HIV disease? J Minnesota Acad Sciences 58(2):27-30, 1994.
  56. Shecterle L, St.Cyr J: Extracorporeal whole body hyperthermia as a treatment option in HIV/AIDS disease, "Low flow technique," Feasibility clinical study, clinical instruction manual, Copyright-Organetics, Ltd., 1994.
  57. St. Cyr JA, Fullerton DA, Zamora M, Hopeman AR: Tracheobranchial disruption: postoperative management with jet ventilation to minimize airway pressure. J Cardiovasc Surg 35(1):79-81, 1994.
  58. Fullerton DA, St. Cyr JA, Fall SM, Whitman GJ: Protection of the patent internal mammary artery by-pass graft from subsequent sternotomy. J Cardiovasc Surg 35(6):499-501, 1994.
  59. Fullerton DA, Kirson LE, St.Cyr JA, Albert JD, Whitman GJR. The influence of respiratory acid-base status on adult pulmonary vascular resistance before and after cardiopulmonary bypass. Year book of Critical Care Medicine, Rogers M (ed.), Mosby-Year Books, Inc., Chicago, Il, 1994.
  60. St.Cyr JA, Shecterle LM: Effects of hypoxia on pulmonary microvascular permeabilibty in the isolated adult rabbit lung. J Biomed Sci 2(1):70-76, 1995.
  61. Shecterle LM, Gasper P, St.Cyr JA: Current and future prospects of whole body hyperthermia for deactivation of HIV. J AIDS Patient Care 9(2):85, 1995.
  62. Shecterle LM, Kelly T, St.Cyr JA: Therapy with extracorporeal whole body hyperthermia. Abstract, Serono Symposia: Idea to product. November, 1994, Washington, D.C., Abstract booklet.
  63. Shecterle LM, Kelly T, Zablow A, St.Cyr JA: Altered lipid metabolism with hyperthermia. FASEB Journal 9(4):A646, 1995.
  64. Shecterle LM, Gasper PW, St.Cyr JA: Hyperthermia as a potential treatment in HIV disease. Alternative Medicine Journal 2(3):28-32, 1995.
  65. Shecterle LM, St.Cyr JA: Letter to the editor, Localized or systematic in vivo heat-inactivation of human immunodeficiency virus (HIV); a mathematical analysis. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10(3):391, 1995.
  66. Shecterle LM, St.Cyr JA: Rate of temperature rise using a hot air whole body hyperthermia device. Southern Med Journal 88(10): PS142, PS143, 1995.
  67. Shecterle LM, Gasper PW, St.Cyr JA: Potential role of using whole body hyperthermia to treat Lyme disease. Southern Med Journal, 88(10): PS142, 1995.
  68. Shecterle LM, Kelly T, St.Cyr JA: Canine Experimentation with low flow extracorporeal whole body hyperthermia. Southern Med Journal 88(10): PS143, 1995.
  69. Shecterle LM, Gasper PW, St.Cyr JA: Could whole body hyperthermia have a role in the treatment of Lyme disease? Alternative Medicine Journal 2(4):19-20, 1995.
  70. Shecterle LM, St.Cyr JA: Whole Body Hyperthermia as a Potential Therapeutic Option, Invited submission. Cancer Biotherapy 10(4):253-256, 1995.
  71. Zablow A, Dorian R, Kelly T, St. Cyr JA: Feasibility trial using extracorporeal whole body hyperthermia in AIDS patients. J Investigative Medicine 44(1):192A, 1996.
  72. Henry K, Erice A, Balfour H, Beatty C, St. Cyr JA: Acute effects of whole body hyperthermia on plasma HIV-RNA levels. Third Conference on Retroviruses and Opportunistic Infections, Washington, DC, p. 26 Abstr 373, 1996.
  73. Shecterle LM, Myers R, Holton M, Kelly T, Zablow A, St.Cyr JA: Inducing whole body hyperthermia using a new extracorporeal device. Hyperthermic Oncology 1996, Vol. 1:261, 1996.
  74. St.Cyr, JA: Medical Minute....Hyperthermia. Medcorp News 5(second quarter):2, 1996.
  75. Fullerton DA, McIntyre RC, Kirson LE, St.Cyr JA, Whitman GJR, Grover FL: Impact of respiratory acid-base status in patients with pulmonary hypertension. Ann Thorac Surg 61:696-701, 1996.
  76. St.Cyr JA, Kelly T, Shecterle LM: Cranial venous effluent temperature assessment during extracorporeal whole body hyperthermia. FASEB Journal 10(3):A118, 1996.
  77. Shecterle LM, Kelly T, Dorian R, St.Cyr JA: Maintenance of renal and hepatic function with dopamine during and following extracorporeal whole body hyperthermia. FASEB Journal 10(3):A119, 1996.
  78. Shecterle LM, Kelly T, St.Cyr JA: Letter to the Editor, Safe and efficient method of inducing whole body hyperthermia. International Journal of Hyperthermia 12(4):569-571, 1996.
  79. St.Cyr JA, Kelly T, Shecterle LM: Whole Body Extracorporeal Low Flow Hyperthermia in a Canine Model. J Extracorporeal Technology 28(3):140-146, 1996.
  80. Shecterle LM, Myers R, Holton M, Kelly T, Zablow A, St.Cyr JA: Inducing whole body hyperthermia using a new extracorporeal device. Hyperthermic Oncology 1996, Vol. 2:275-277, 1996.
  81. Zablow A, Dorian R, Myers R, Holton M, Kelly T, Shecterle L, St.Cyr J: Use of low flow extracorporeal whole body hyperthermia in the treatment of HIV disease, a feasibility study. Southern Med J 89(10):S150-51, 1996.
  82. Shecterle LM, St.Cyr JA: The effects of radiant rewarming on pH (corrected vs uncorrected) in severely hypothermic canines. FASEB Journal 2:A526, 1997.
  83. Shecterle LM, Kelly T, St.Cyr JA: Response, Letter to the Editor, “Safe and efficient method for inducing whole body hyperthermia.” International J Hyperthermia 13(3):339-340, 1997.
  84. Shecterle LM, St.Cyr JA: A further comment on alternative HIV therapies. The Scientist 11(9):10, 1997.
  85. Zablow A, Shecterle L, Dorian R, Kelly T, Fletcher S, Forman M, Sanfilippo L, St.Cyr J: Extracorporeal whole body hyperthermia treatment in HIV patients, a feasibility study. Int J Hyperthermia 13(6):577-586, 1997.
  86. Shecterle LM, St.Cyr JA: Hyperthermia in Medicine. Proc 4th Int Symposim on Biol Closed Elect Circuits, pp 286-289, 1997.
  87. Shecterle LM, Wetherall NT, St.Cyr JA: Hyperthermia alters HIV kinetics, Results of a study. Alternative Therapies in Clinical Practice 4(5):162-164, 1997.
  88. Shecterle LM, St.Cyr JA: Twelve month follow up in advanced HIV patients treated with whole body hyperthermia. Onkologie, J of Oncology 29(suppl 4a):12, 1997.
  89. Shecterle LM, Wetherall NT, St.Cyr JA: Hyperthermia affects complement levels. J Investigative Medicine 46(1):50A, 1997.
  90. Shecterle LM, St.Cyr JA: Potential resolution of Zidovudine (AZT) anemia. J Investigative Medicine 46(1):65A, 1997.
  91. Shecterle,LM, St.Cyr JA: Radiant rewarming for hypothermia: pilot canine study model. Journal Minnesota Academy of Science 62(1):12-16, 1997.
  92. Shecterle LM, St.Cyr JA: US Patent, “Double Layer Prophylactic Incorporating Pharmacological Fluid and Spiral Barrier Layer,” USP5623945, 1997.
  93. Myers R, Holton M, Kelly T, St.Cyr J, Dorian R, Cavanaugh L: The use of extracorporeal whole body hyperthermia in HIV/AIDS patients. Abstract, AMSECT meeting, 1998.
  94. Shecterle LM, Clark L, St.Cyr JA: Metastatic prostate cancer treated with whole body hyperthermia: a case report. J Investigative Medicine 46(3):242A, 1998.
  95. Zablow A, Shecterle LN, Kelly T, St.Cyr JA: Response to the letter to the Editor: Hyperthermia and AIDS: a Critical Review. Int J Hyperthermia 14(4):419, 1998.
  96. St.Cyr J, Wetherall, N, Wernes L, Shecterle L, Blick G, Greiger P: HIV is heat sensitive In Vitro. FASEB Journal 47(4):210A, 1999.
  97. Rakow N, Nelson D, Boldt C, Pfenning K, McClay C, Waskiewicz J, Shecterle L, St.Cyr J: Chronic orthotopic aortic valve implantation model. Proceedings from the World Symposium on Heart Valve Disease. London, UK, page 188, 1999.
  98. Shecterle L, Zablow A, Kelly T, St.Cyr J: Abnormal cervical histopathology reversed with whole body hyperthermia. FASEB Journal 47(4):208A, 1999.
  99. Shecterle LM, St.Cyr JA: Response to a Letter to the Editor, “More on Hepatitis C,” The Scientists 13(11):12, 1999.
Animal Science and Research Flyer